BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li W, Li DD, Yin B, Lin DD, Sheng HS, Zhang N. Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: A case report. World J Clin Cases 2021; 9(3): 651-658 [PMID: 33553404 DOI: 10.12998/wjcc.v9.i3.651]
URL: https://www.wjgnet.com/2307-8960/full/v9/i3/651.htm
Number Citing Articles
1
Ziyu Li, Yuling An, Lijuan Li, Huimin Yi. Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the LiteratureInfection and Drug Resistance 2022; : 1411 doi: 10.2147/IDR.S354460
2
Qi Huang, Xingwen Zhang, Aijun Jia, Qi Huang, Yu Jiang, Liangyi Xie. The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial InfectionInfection and Drug Resistance 2022; : 4809 doi: 10.2147/IDR.S377772
3
Antonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, Filippo Urso, Roberto Manfredi, Sonia Greco. Intrathecal tigecycline is a safe and effective treatment for central nervous system infectionsencephalitis 2023; 3(3): 87 doi: 10.47936/encephalitis.2023.00010
4
Ning Du, En-Qiang Mao, Zhi-Tao Yang, Hong-Ping Qu, Xian Qian, Ying Shi, Xiao-Lan Bian, Juan He, Er-Zhen Chen. Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniaeInfection and Drug Resistance 2022; : 7219 doi: 10.2147/IDR.S387346
5
Xiaoxia Li, Junnian Liu, Xinyu Zhang, Juan Li, Luhan Xuan, Sue Yuan, Jianglin Li, Yu Sun, Xuefei Du. Comparative Genomic Analysis of Tigecycline Resistance Development in Clinical Acinetobacter baumannii IsolatesInfection and Drug Resistance 2025; : 4263 doi: 10.2147/IDR.S539267